Advani A, Mughal SA. Luspatercept (REBLOZYL): A Game-Changer in Reducing Transfusion Burden for β-Thalassemia Patients. IRABCS [Internet]. 2025 Jun. 30 [cited 2025 Nov. 4];3(1):80-1. Available from: https://irjpl.org/irabcs/article/view/150